Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raloxifene effects on depressive symptoms in postmenopausal osteoporosis
NCT03006003Phase 4Unknown
- Sponsor
- Taichung Veterans General Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raloxifene in osteoporosis, sponsored by Taichung Veterans General Hospital. Status: unknown.
02
Drugs
raloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT03006003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03006003.